“…The active ingredient in three commercially available pharmaceutical drugs could be effectively prepared via an aminocarbonylation with CO produced from the electrochemical reduction of CO 2 , including the PARP inhibitor, olaparib ( 4 , 86% yield), the tyrosine-kinase inhibitor, sunitinib ( 5 , 66% yield) and the D 2 -receptor antagonist, itopride ( 6 , 63% yield). Other compounds successfully prepared from an aminocarbonylative step include thiophene carboxamide 7 (84% yield), the H3-receptor antagonist 8 (79% yield), oxadiazole 9 (73% yield) prepared from a dehydrative cyclisation of the intermediate diacyl hydrazide 33 , and the melanoma positron emission tomography tracer 10 (83% yield). Resorting to a Pd-catalysed alkoxycarbonylation also proved viable providing the local anesthetic, butoxycaine ( 11 ) and the cyclopropyl ester 12 in good yields, 98 and 69%, respectively.…”